During the past decade, Pius-Hospital, Oldenburg conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 14 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 9 clinical trials were completed. i.e. 64.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pius-Hospital, Oldenburg" #1 sponsor was "University of Ulm" with 7 trials, followed by "AIO-Studien-gGmbH" with 4 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pius-Hospital, Oldenburg" #1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Amgen" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "Novartis Pharmaceuticals" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Pius-Hospital, Oldenburg" are "Carcinoma, Non-Small-Cell Lung" (12 trials), "NSCLC" (5 trials), "Non-Small Cell Lung Cancer" (5 trials), "Acute Myeloid Leukemia (AML)" (4 trials) and "Acute Myeloid Leukemia" (3 trials). Many other conditions were trialed in "Pius-Hospital, Oldenburg" in a lesser frequency.

Most popular intervention types in "Pius-Hospital, Oldenburg" are "Drug" (54 trials), "Other" (7 trials), "Biological" (6 trials), "Radiation" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pemetrexed" (11 trials), "Carboplatin" (10 trials), "Cisplatin" (7 trials), "Placebo" (6 trials) and "Cytarabine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Pius-Hospital, Oldenburg" are 61 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Pius-Hospital, Oldenburg". undefined are not yet recruiting, 10 are recruiting, 14 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in Pius-Hospital, Oldenburg, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Pius-Hospital, Oldenburg, 4 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Pius-Hospital, Oldenburg has several departments that took part in Clinical trials: "Pius-Hospital; Klinik fuer Haematologie und Onkologie" - 9 trials